These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    Author: D'Alessandro G, Bianco MR, Politis S, Ferrandina C, Rossi G, Altomare E.
    Journal: Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489.
    Abstract:
    Anti TNF-alpha drugs seem to be the new frontier of Rheumatoid Arthritis (RA) therapy. The association infliximab methotrexate has been approved for the treatment of RA not responding to the classic therapy, but the short clinical experience in using antiTNF-alpha molecules brings to segnalation of new risks or adverse events. We describe a case of a patient, treated for many years with classic RA therapy, which developed a refractory anemia after treatment with association infliximab-methotrexate.
    [Abstract] [Full Text] [Related] [New Search]